Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2015 | 1 |
2020 | 1 |
2022 | 1 |
2023 | 1 |
Search Results
4
results
Results by year
Page 1
Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer.
ERJ Open Res. 2022 Oct 17;8(4):00239-2022. doi: 10.1183/23120541.00239-2022. eCollection 2022 Oct.
ERJ Open Res. 2022.
PMID: 36267895
Free PMC article.
RSV infection among children born moderately preterm in a community-based cohort.
Gijtenbeek RG, Kerstjens JM, Reijneveld SA, Duiverman EJ, Bos AF, Vrijlandt EJ.
Gijtenbeek RG, et al.
Eur J Pediatr. 2015 Apr;174(4):435-42. doi: 10.1007/s00431-014-2415-2. Epub 2014 Sep 6.
Eur J Pediatr. 2015.
PMID: 25189655
Clinical Trial.
Item in Clipboard
Nationwide Real-world Cohort Study of First-line Tyrosine Kinase Inhibitor Treatment in Epidermal Growth Factor Receptor-mutated Non-small-cell Lung Cancer.
Gijtenbeek RGP, Damhuis RAM, Groen HJM, van der Wekken AJ, van Geffen WH.
Gijtenbeek RGP, et al.
Clin Lung Cancer. 2020 Nov;21(6):e647-e653. doi: 10.1016/j.cllc.2020.05.019. Epub 2020 May 22.
Clin Lung Cancer. 2020.
PMID: 32636159
Item in Clipboard
Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study.
Gijtenbeek RGP, Damhuis RAM, van der Wekken AJ, Hendriks LEL, Groen HJM, van Geffen WH.
Gijtenbeek RGP, et al.
Lancet Reg Health Eur. 2023 Feb 6;27:100592. doi: 10.1016/j.lanepe.2023.100592. eCollection 2023 Apr.
Lancet Reg Health Eur. 2023.
PMID: 36817181
Free PMC article.
Item in Clipboard
Cite
Cite